Halozyme Therapeutics, Inc. (HALO) Thursday revealed the appointment of Darren Snellgrove as Chief Financial Officer, effective June 8, 2026.
Most recently, Snellgrove was with Johnson & Johnson leading investor relations. He brings more than 30 years experience.
Snellgrove will be responsible for leading Halozyme's financial operations and strategy, including capital allocation, corporate development and investor relations.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.